Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients

doi:10.12998/wjcc.v9.i4.792

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

304

WORD

188

HTML

2085

Figures (1-2)

267

Tables (1-2)

244

Sum=3088

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

329

Download

824

Sum=1153

Publishing Process of This Article

Item

Count

Browse

449

Download

1078

Sum=1527

Feb 6, 2021 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Feb 6, 2021; 9(4): 792-800
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.792

Open in New Tab Full Size Figure Download Figure

Figure 1 Radioactive ¹²⁵I seeds implanted in pancreatic cancer patients with unexpected liver metastasis. A: Preoperative computed tomography (CT) showed the primary pancreatic cancer (arrow); B: Postoperative CT showed the radioactive ¹²⁵I seeds implanted in the pancreatic cancer.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier cumulative survival curves according to chemotherapy status. The median survival for 7 patients who received chemotherapy was 16.3 mo, which was significantly longer than that for 17 patients who did not (10 mo; P = 0.008).

Citation: Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive ¹²⁵I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients. World J Clin Cases 2021; 9(4): 792-800
URL: https://www.wjgnet.com/2307-8960/full/v9/i4/792.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i4.792